Shelter Pharma Limited (BOM:543963)
India · Delayed Price · Currency is INR 26.74
+1.54 (6.11%)
At close: Aug 17, 2026
Shelter Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 90.27 | 72.37 | 62 | 52.06 | 18.37 |
Depreciation & Amortization | 4.1 | 2.68 | 2.46 | 1.64 | 1.69 |
Other Amortization | - | 0.01 | - | - | - |
Provision & Write-off of Bad Debts | - | - | 3 | - | - |
Other Operating Activities | -0.35 | -0.02 | 5.55 | 18.55 | 5.46 |
Change in Accounts Receivable | -23.32 | -6.25 | -6.55 | -65.89 | -8.46 |
Change in Inventory | -115.44 | -29.66 | -20.66 | -22.9 | -16.59 |
Change in Accounts Payable | 0.03 | 5.37 | 2.47 | 1.45 | 0.11 |
Change in Other Net Operating Assets | -80.09 | 10.32 | -67.88 | 5.46 | 4.59 |
Operating Cash Flow | -124.8 | 54.82 | -19.62 | -9.64 | 5.17 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -15.9 | -26.51 | -8.52 | -0.04 | -6.05 |
Investment in Securities | - | - | - | - | -0.01 |
Other Investing Activities | 0.16 | 0.06 | 0.01 | 0.02 | 0 |
Investing Cash Flow | -145.52 | -71.28 | -45.44 | 1.13 | -8.52 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 1.54 | - | - | - | - |
Long-Term Debt Issued | - | 3.58 | 0.93 | 4.8 | 0.65 |
Total Debt Issued | 1.54 | 3.58 | 0.93 | 4.8 | 0.65 |
Long-Term Debt Repaid | -3.97 | - | - | - | - |
Net Debt Issued (Repaid) | -2.43 | 3.58 | 0.93 | 4.8 | 0.65 |
Issuance of Common Stock | - | - | 109.12 | - | - |
Common Dividends Paid | -3.78 | -3.82 | - | - | - |
Other Financing Activities | 253.12 | 0.49 | - | -2.01 | - |
Financing Cash Flow | 246.91 | 0.26 | 110.06 | 2.79 | 0.65 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | - | - | 9 | -0 |
Net Cash Flow | -23.41 | -16.2 | 45 | 3.28 | -2.7 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -140.7 | 28.32 | -28.14 | -9.68 | -0.88 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -19.24% | 5.59% | -7.03% | -2.68% | -0.29% |
Free Cash Flow Per Share | -8.04 | 2.45 | -2.43 | -1.25 | -0.11 |
Levered Free Cash Flow | -154.43 | 16.1 | -52.69 | -21.17 | -3.05 |
Unlevered Free Cash Flow | -153.76 | 16.1 | -51.37 | -21.13 | -2.66 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Income Tax Paid | 31.67 | 24.36 | 15.6 | - | - |
Change in Working Capital | -218.82 | -20.22 | -92.62 | -81.89 | -20.35 |